Patrick Frost, PhD

Patrick Frost, PhD

Jan 23, 2016

Group 6 Copy 44
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Assemblase: A New Platform Technology for Protein Scaffolding

We have designed a novel protein scaffold onto which we can attach the enzymes from any pathway, creating...

Bee battles: are our native bees losing the fight for resources?

Is a recently introduced invasive species, the European wool-carder bee, threatening our native bumble bees...

Backer Badge Funded